Hedge Fund - Armistice Capital
Travere Therapeutics Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $66,382,160 | 0.9% | 7,384,000 | $ |
| 2 | 2023 - Q3 (2023-09-30) | $67,050,000 | 1.02% | 7,500,000 | $ |
| 3 | 2023 - Q2 (2023-06-30) | $114,432,000 | 1.65% | 7,450,000 | $ |
| 4 | 2023 - Q1 (2023-03-31) | $160,758,520 | 2.31% | 7,148,000 | $ |
| 5 | 2022 - Q4 (2022-12-31) | $134,844,360 | 2.35% | 6,412,000 | $ |
| 6 | 2022 - Q3 (2022-09-30) | $143,799,000 | 2.49% | 5,836,000 | $ |
| 7 | 2022 - Q2 (2022-06-30) | $128,904,000 | 2.24% | 5,320,000 | $ |
| 8 | 2022 - Q1 (2022-03-31) | $127,768,000 | 2.47% | 4,958,000 | $ |
| 9 | 2021 - Q4 (2021-12-31) | $126,581,000 | 2.07% | 4,078,000 | $ |
| 10 | 2021 - Q3 (2021-09-30) | $115,139,000 | 1.95% | 4,748,000 | $ |
| 11 | 2021 - Q2 (2021-06-30) | $83,863,000 | 1.5% | 5,748,000 | $ |
| 12 | 2021 - Q1 (2021-03-31) | $58,829,000 | 1.35% | 2,356,000 | $ |
The displayed share prices are average quarterly stock market prices.